Petra Wetzel,3
Cornelia Geers,3
Mary Ann Robinson,4
Timothy G. Myers,4
Jennie W. Owens,5
Nancy B. Wehr,1
Michael W. Eckhaus,5
Gerolf Gros,3
Anthony Wynshaw-Boris,6,
and
Rodney L. Levine1*
Laboratories of Biochemistry,1 Cell Signaling, National Heart, Lung, and Blood Institute,2 Research Technologies Branch, National Institute of Allergy and Infectious Diseases,4 Division of Veterinary Resources, Office of Research Services,5 Laboratory of Genetic Disease Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland,6 Zentrum Physiologie, Medizinische Hochschule Hannover, Hannover, Germany3
Received 4 June 2004/ Returned for modification 15 August 2004/ Accepted 19 August 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
3% of that of Car2 (13, 14). Car3 had been thought to also possess intrinsic tyrosine phosphatase activity, but that was subsequently found to be due to a contaminating phosphatase (12). The enzyme is remarkably abundant in skeletal muscle (3) and adipocytes (31), constituting up to 8 and 25% of the soluble fraction of these tissues. Car3 expression is negligible in preadipocytes, becoming substantial upon differentiation (21), but the mechanism of differentiation-dependent Car3 expression is not understood. Despite the notable abundance of Car3 in fat and muscle, its function is unknown, although it has been implicated in fatty acid metabolism (22). Car3 could facilitate rapid conversion of glycolytic intermediates to oxaloacetate and citrate and stimulate their incorporation into fatty acids. However, adipocyte Car3 expression in obese mice is lower than that in lean mice (21, 32). Exposure of differentiated mouse adipocytes to insulin decreased Car3 expression by 90% while expression of Car2 was unchanged (20).
Car3 has two reactive sulfhydryl groups which can conjugate to glutathione through a disulfide link, a process termed S-glutathionylation (4, 19). Car3 is rapidly glutathionylated in vivo and in vitro when cells are exposed to oxidative stresses, and it is one of the most carbonylated proteins in rodent liver. These observations have led to the suggestion that the enzyme plays a role in the cellular response to oxidative stresses, including reperfusion injury and aging (2, 35). Expression of Car3 in cells lacking the protein protects them from hydrogen peroxide-induced apoptosis, while expression of the closely related Car2 does not (24).
We utilized targeted gene deletion to create a mouse lacking Car3, for the purpose of elucidating the normal function of Car3. We now report studies which characterize this knockout mouse.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Anatomical examinations. Detailed gross and histological examinations were performed on two male and two female knockout mice, plus one wild-type mouse of each sex. All of the mice were well hydrated and well muscled and contained ample body fat. The heart, liver, and kidneys of each mouse were weighed. Representative samples of the following organs or tissues were obtained for histopathology: brain, liver, spleen, pancreas, kidneys, urinary bladder, adrenal glands, heart, lung, thyroid gland, salivary gland, submandibular lymph node, thymus, eyes, hind limb skeletal muscle, tongue, stomach, small intestine, cecum, colon, skin, bone marrow, brown adipose tissue, testis, epididymis, ovary, and uterus. Tissues were fixed in 10% neutral buffered zinc formalin (Z-fix; Anatech, Battle Creek, Mich.) and processed for routine histologic examination at 6 µm. Tissues were stained with hematoxylin and eosin.
For electron microscopic studies, samples of liver, brown fat, white fat, and skeletal muscle (gastrocnemius and soleus) from Car3+/+ and Car3/ mice were fixed in 2.5% glutaraldehyde-0.1 M cacodylate buffer and postfixed in 1% osmium tetroxide. Tissues were dehydrated through alcohol and propylene oxide and then embedded in Eponate 12 resin (Ted Pella, Redding, Calif.). Thin sections were prepared with a Leica Ultracut UCT ultramicrotome and stained with uranyl acetate and lead citrate. Sections were examined under a Philips 201 electron microscope.
Kaplan-Meier survival analysis was calculated with the WinSTAT plug-in for Microsoft Excel (Robert Finch Software, Calumet City, Ill.).
Biochemical and physiological analyses. Fatty acid analysis of whole-tissue extracts was performed in the Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, by gas chromatography-mass spectrometry as described previously (23). Tissue carbonyl content was determined both spectrophotometrically and by Western blotting of SDS-polyacrylamide gels (18) Carbonic anhydrase activity was determined as described previously (12).
Western blots were performed with antisera to recombinant Car3 (12). Tissues were homogenized in Nonidet P-40 lysis buffer (1% Nonidet P-40, 25 mM Tris-HCl [pH 7.5], 140 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 µg of aprotinin/ml, 1 µg of leupeptin/ml, 1 µg of pepstatin/ml, and 1 mM sodium vanadate). Proteins in the lysates were separated by electrophoresis on SDS-10% polyacrylamide gels and then transferred to nitrocellulose membranes (Millipore, Bedford, Mass.). After being blocked with 5% nonfat milk in phosphate-buffered saline (150 mM NaCl, 8 mM Na2HPO4, 2 mM KH2PO4, 3 mM KCl, pH 7.4) containing 0.1% Tween 20, the filters were incubated with Car3 antibody, followed by incubation with anti-rabbit immunoglobulin G coupled to horseradish peroxidase (Kirkegaard & Perry Laboratories, Gaithersburg, Md.).
Contractile parameters were determined for isolated whole soleus muscle (9) and in fiber bundles of soleus muscle as described previously (37). Briefly, muscles or fiber bundles were incubated in modified Krebs-Henseleit solution (120 mM NaCl, 4 mM KCl, 1 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, 1 mM CaCl2, and 5.5 mM glucose); equilibrated with 95% O2-CO2, pH 7.4, at 25°C; and directly stimulated under isometric conditions at optimal length with supramaximal voltage. Single-twitch and tetanic contractions (50 Hz, 1.5 s) were analyzed for tension and contraction times. The fatigue protocol for fiber bundles elicited one 1.2-s tetanic contraction at 15 Hz every 5 s for 45 min. At the end of the fatigue protocol, myosin heavy chain content was analyzed (15). A hyperoxia challenge (8) was administered by placing the caged mice, with food and water, inside a large AtmosBag (Sigma-Aldrich) previously flushed with oxygen. After the bag was taped closed, oxygen was bled into the bag at a constant flow to maintain the oxygen concentration at
99%, monitored by a MiniOx I oxygen analyzer (Catalyst Research, Pittsburgh, Pa.). Animals were observed at least every 1 to 2 h; moribund animals were removed and killed.
Exercise tolerance was assessed on a motor-driven treadmill (Columbus Instruments, Columbus, Ohio). Three 12-month-old male mice of each genotype were familiarized with the treadmill the day before formal testing by running them twice at 0.2 m/min for 5 min. The next day they were then tested at a treadmill speed of 0.3 m/min, running until they failed to move despite an electrical stimulus. Each mouse was tested five different times, and the results were averaged to give the endurance time for the mouse.
Microarray analyses. (i) RNA and array preparation. RNA was prepared from three male and three female wild-type and knockout mice by extraction with phenol-guanidine isothiocyanate (5) (Trizol reagent; Invitrogen, Carlsbad, Calif.). The aqueous phase was brought to 70% ethanol, applied to an RNeasy Midi spin column, and processed according to the directions of the manufacturer (Qiagen, Valencia, Calif.). Brain, kidney, liver, soleus (a type I or slow-twitch muscle), and gastrocnemius (a type II or fast-twitch muscle) were separately extracted from each of the 12 mice, but because of the small yield from the soleus, samples were combined from the three animals within each sex-genotype group. Six arrays (three typical and three dye-flipped) were hybridized for each sex and tissue type (four for soleus). Evaluation and analysis of the large volume of data generated by this number of arrays required additional techniques, described below.
Microarrays were prepared in the Microarray Research Facility of the National Institute of Allergy and Infectious Diseases, printed as described by the Brown laboratory (http://cmgm.stanford.edu/pbrown/protocols/index.html). The 13,443 oligonucleotide probes were 70-mers (Mouse Genome Oligo Set Version 1.0; Qiagen); the corresponding genes are listed at http://oligos.qiagen.com/arrays/omad.php and include carbonic anhydrases 1, 2, 3, 4, 5a, 5b, 6, 7, 13, 14, and 15 and carbonic anhydrase-like 1. Total RNA (20 µg) was labeled with Cy3 or Cy5 with the Fairplay Microarray labeling kit (Stratagene). Hybridizations were performed with a procedure adapted from the work of Hegde and colleagues (10). The microarrays were prehybridized for 1 h at 42°C in a buffer of 750 mM sodium chloride-750 mM sodium citrate-1% bovine serum albumin-0.1% SDS at pH 7.0. The slides were washed twice with water and once with isopropanol and then dried by centrifugation at 1,000 x g for 3 min (Beckman Allegra 6 centrifuge; Fullerton, Calif.). The labeled targets were brought to 30 ml in 10 mM Tris-1 mM EDTA, pH 8.0, to which was added 4 µg of yeast tRNA (Sigma, St. Louis, Mo.), 1 µg of poly(dA)40-60 (Amersham Pharmacia, Piscataway, N.J.), and 10 µg of human Cot-1 DNA (Invitrogen). The targets were denatured by being heated to 98°C for 2 min and then mixed with 33 µl of hybridization buffer (1.5 M sodium chloride, 1.5 M sodium citrate, 0.2% SDS, pH 7.0). Hybridization was carried out in a sealed, humidified chamber submerged in a water bath at 42°C for 14 to 18 h.
(ii) Measurement of change in expression. Fluorescence scanning and image analysis were performed using Axon Gene Pix Pro software (Axon Instruments, Union City, Calif.). Signal values for each channel were taken as the difference between the fluorescence pixel mean and the background pixel median. In cases where the pixel mean for a spot did not exceed the calculated background mean by more than twice the background pixel standard deviation, the raw (non-background-subtracted) fluorescence value was used. Expression change was calculated for each spot as log (base 2) of the ratio of signal in the two channels. A value of 2 is a fourfold increase in expression relative to the reference sample. A value of 2 conveys a decrease in expression to one-fourth of that in the reference sample.
(iii) Normalization and evaluation. For each array, overall signal in both channels was balanced by nonlinear regression with the Loess normalization. Proc Loess (SAS Institute, Cary, N.C.) was used with the following parameters to fit expression change versus the average signal for both channels: smooth = 0.7, degree = 1, and iterations = 10. This method seeks to balance the two fluorescence channels by setting the average expression change to zero at every level of average signal. Utilizing the assumption that the overwhelming majority of spots will have expression change equal to zero, the method seeks to correct for bias due to differences in dye performance and other systematic inequalities between the two fluorescence channels, whether or not the magnitude of the inequality is dependent on the magnitude of the fluorescence signal.
Each set of matching spots (that is, the same gene over all arrays) was also checked for dye bias by testing for a difference in expression change when the Cy3-Cy5 dye used on the reference sample differed ("dye flip" trials). By design, this is a comparison of three arrays to another three arrays. In some cases fewer than three qualifying values are available per group.
Expression change was detected by testing against the null hypothesis that there was no difference of the sample from the reference sample by using a one-sample t test with Proc Univariate (SAS). A "volcano plot" convention was used to display the results (38).
| RESULTS |
|---|
|
|
|---|
Growth and life span. We determined the postnatal growth patterns for the mice as an integrated assessment of biological health and also because Car3 is particularly rich in adipocytes. Sex-specific growth curves of the wild-type, heterozygous, and knockout animals were superimposable through 80 days of life, when measurements were stopped. We recorded age at death of animals allowed to reach their life span. No effect on life span was observed (Fig. 2).
|
Effect of stress. As mentioned above, Car3 is abundant in muscle, especially slow-twitch muscles such as the soleus. Habitus and gait were normal to our observation. We then attempted to uncover a possible role for the enzyme by testing the animals' endurance with a treadmill test. As shown in Table 1, knockout mice performed as well as did their wild-type littermates.
|
100% oxygen. Adult rodents typically die with pulmonary edema after 3 to 4 days of exposure, but other organs including brain and liver demonstrate oxidative damage within the first day of exposure (33). No difference was detected in time of survival between the wild-type and Car3-knockout animals (Table 2).
|
Contractile properties of isolated muscle. The contractile properties of whole soleus muscle, rich in Car3, were compared between wild-type and Car3-knockout animals (Table 3). The Car3/ muscles had shorter half-relaxation times for both single and tetanic twitches. Car3/ solei had a minor reduction of tetanic force when normalized to their cross-sectional area. Soleus fiber bundles from Car3/ mice also exhibited shorter relaxation times for both single-twitch and tetanic contractions (data not shown). Cote and colleagues reported that inhibition of Car3 by millimolar concentrations of methazolamide rendered mouse soleus muscle more resistant to fatigue (6). We therefore tested the fatigability of soleus muscle from our mice. Fatigue was induced in both whole soleus and isolated fiber bundles (Fig. 3); there was no difference in fatigability between Car3+/+ and Car3/ animals.
|
|
The microarray included probes for 10 other mouse carbonic anhydrase isozymes (Fig. 4). A statistically significant increase in expression of Car13 was detected, although the increase was only
30% ± 10%. Whether the Car13 protein and activity are changed and what the physiological impact is remain to be investigated, particularly as the first characterization of Car13 has just been published (16).
|
| DISCUSSION |
|---|
|
|
|---|
Lack of Car3 in the slow muscle soleus does not affect the fiber type composition, as assessed by analysis of myosin heavy chain I. Important contraction parameters such as time-to-peak and single-twitch force are unaltered, suggesting that the major muscular functions, the calcium release mechanism, and the contractile apparatus are not affected. It is not clear why the half-relaxation times of single twitches and of tetani are reduced. The observation is difficult to interpret because these relaxation times are affected by a multitude of cellular parameters, including pH, phosphate concentration, ADP level, and others. We conclude that, although minor disturbances may have occurred in the muscle cell, its major properties appear unchanged.
Given the large number of carbonic anhydrases, it may be that other isozymes are sufficient for normal cellular function when Car3 is lacking. While possible, this is somewhat unattractive as an explanation because the specific activity of Car3 as a carbonic anhydrase is so low, being
3% of that of Car2. Furthermore, loss of Car2 has a profound phenotype in humans, causing Guibaud-Vainsel syndrome or marble brain disease, a syndrome which includes osteopetrosis, renal tubular acidosis, and cerebral calcification (29).
Alternatively, it may be that Car3 is required for an effective response to specific stimuli or stresses which mice do not encounter in the laboratory animal facility. This consideration led us to compare wild-type and Car3-deficient mice on the exercise treadmill and upon exposure to hyperoxia. These stresses did not reveal differences between the genotypes. We suspect that there will be stresses to which the knockout animals respond poorly, although we have not yet identified them.
As implied above when we noted its low specific activity, Car3 may not actually function as a carbonic acid anhydrase. Identification of a new catalytic activity acquired by Car3 would likely provide insight into the protein's physiological role. Although entirely speculative, an intriguing possibility is that Car3 has evolved into a percarbonic acid anhydrase. While carbonic anhydrase mediates the reaction of carbon dioxide with water, H2O + CO2
H2CO3, a percarbonic anhydrase would mediate the reaction of carbon dioxide with hydrogen peroxide, H2O2 + CO2
H2CO4. Richardson and colleagues have studied the chemistry of this reaction and shown that, under their solvent conditions, percarbonic acid is a powerful oxidizing agent which could readily oxidize methionine residues of proteins to methionine sulfoxide (26, 27).
Whether acting as a percarbonic anhydrase or as another enzyme, Car3 expression decreased the level of reactive oxygen species when expressed in NIH 3T3 cells and protected them against cytotoxic concentrations of hydrogen peroxide (24). Thus, Car3 may function as a member of the defense system against oxidative stresses, a function which could explain the large fraction of Car3 which is itself oxidatively modified in vivo (2, 28).
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Present address: Department of Oral Biochemistry, College of Dentistry, Chonnam National University, Kwangju, South Korea. ![]()
Present address: Departments of Pediatrics and Medicine, University of California, San Diego School of Medicine, La Jolla, Calif. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Cabiscol, E., and R. L. Levine. 1995. Carbonic anhydrase III. Oxidative modification in vivo and loss of phosphatase activity during aging. J. Biol. Chem. 270:14742-14747.
3. Carter, N. D. 1991. Hormonal and neuronal control of carbonic anhydrase III gene expression in skeletal muscle, p. 247-256. In S. J. Dodgson, R. E. Tashian, G. Gross, and N. D. Carter (ed.), The carbonic anhydrases: cellular physiology and molecular genetics. Plenum Publishing Corp., New York, N.Y.
4. Chai, Y. C., C.-H. Jung, C.-K. Lii, S. S. Ashraf, S. Hendrich, B. Wolf, H. Sies, and J. A. Thomas. 1991. Identification of an abundant S-thiolated rat liver protein as carbonic anhydrase III. Characterization of S-thiolation and dethiolation reactions. Arch. Biochem. Biophys. 284:270-278.[CrossRef][Medline]
5. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.[Medline]
6. Cote, C. H., N. Jomphe, A. Odeimat, and P. Fremont. 1994. Carbonic anhydrase in mouse skeletal muscle and its influence on contractility. Biochem. Cell Biol. 72:244-249.[Medline]
7. Deng, C., A. Wynshaw-Boris, F. Zhou, A. Kuo, and P. Leder. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921.[CrossRef][Medline]
8. Frank, L., J. R. Bucher, and R. J. Roberts. 1978. Oxygen toxicity in neonatal and adult animals of various species. J. Appl. Physiol. 45:699-704.
9. Geers, C., and G. Gros. 1990. Effects of carbonic anhydrase inhibitors on contraction, intracellular pH and energy-rich phosphates of rat skeletal muscle. J. Physiol. 423:279-297.
10. Hegde, P., R. Qi, K. Abernathy, C. Gay, S. Dharap, R. Gaspard, J. E. Hughes, E. Snesrud, N. Lee, and J. Quackenbush. 2000. A concise guide to cDNA microarray analysis. BioTechniques 29:548-556.[Medline]
11. Kim, G., T. Lee, A. Wynshaw-Boris, and R. L. Levine. 2001. Nucleotide sequence and structure of the mouse carbonic anhydrase III gene. Gene 265:37-44.[CrossRef][Medline]
12. Kim, G., J. Selengut, and R. L. Levine. 2000. Carbonic anhydrase III: the phosphatase activity is extrinsic. Arch. Biochem. Biophys. 377:334-340.[CrossRef][Medline]
13. Koester, M. K., L. M. Pullan, and E. A. Noltmann. 1981. The p-nitrophenyl phosphatase activity of muscle carbonic anhydrase. Arch. Biochem. Biophys. 211:632-642.[CrossRef][Medline]
14. Koester, M. K., A. M. Register, and E. A. Noltmann. 1977. Basic muscle protein, a third genetic locus isoenzyme of carbonic anhydrase? Biochem. Biophys. Res. Commun. 76:196-204.[CrossRef][Medline]
15. Kubis, H. P., and G. Gros. 1997. A rapid electrophoretic method for separating rabbit skeletal muscle myosin heavy chains at high resolution. Electrophoresis 18:64-66.[CrossRef][Medline]
16. Lehtonen, J., B. Shen, M. Vihinen, A. Casini, A. Scozzafava, C. T. Supuran, A. K. Parkkila, J. Saarnio, A. J. Kivela, A. Waheed, W. S. Sly, and S. Parkkila. 2004. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J. Biol. Chem. 279:2719-2727.
17. Levine, R. L. 2002. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic. Biol. Med. 32:790-796.[CrossRef][Medline]
18. Levine, R. L., N. Wehr, J. A. Williams, E. R. Stadtman, and E. Shacter. 2000. Determination of carbonyl groups in oxidized proteins. Methods Mol. Biol. 99:15-24.[Medline]
19. Lii, C. K., Y. C. Chai, W. Zhao, J. A. Thomas, and S. Hendrich. 1994. S-thiolation and irreversible oxidation of sulfhydryls on carbonic anhydrase III during oxidative stress: a method for studying protein modification in intact cells and tissues. Arch. Biochem. Biophys. 308:231-239.[CrossRef][Medline]
20. Lynch, C. J., W. A. Brennan, Jr., T. G. Vary, N. D. Carter, and S. J. Dodgson. 1993. Carbonic anhydrase III in obese Zucker rats. Am. J. Physiol. 264:E621-E630.
21. Lynch, C. J., K. M. McCall, M. L. Billingsley, L. M. Bohlen, S. P. Hreniuk, L. F. Martin, L. A. Witters, and S. J. Vannucci. 1992. Pyruvate carboxylase in genetic obesity. Am. J. Physiol. 262:E608-E618.
22. Lyons, G. E., M. E. Buckingham, S. Tweedie, and Y. H. Edwards. 1991. Carbonic anhydrase III, an early mesodermal marker, is expressed in embryonic mouse skeletal muscle and notochord. Development 111:233-244.[Abstract]
23. Moriguchi, T., J. Loewke, M. Garrison, J. N. Catalan, and N. Salem, Jr. 2001. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J. Lipid Res. 42:419-427.
24. Raisanen, S. R., P. Lehenkari, M. Tasanen, P. Rahkila, P. L. Harkonen, and H. K. Vaananen. 1999. Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J. 13:513-522.
25. Register, A. M., M. K. Koester, and E. A. Noltmann. 1978. Discovery of carbonic anhydrase in rabbit skeletal muscle and evidence for its identity with "basic muscle protein. " J. Biol. Chem. 253:4143-4152.
26. Richardson, D. E., C. A. Regino, H. Yao, and J. V. Johnson. 2003. Methionine oxidation by peroxymonocarbonate, a reactive oxygen species formed from CO2/bicarbonate and hydrogen peroxide. Free Radic. Biol. Med. 35:1538-1550.[CrossRef][Medline]
27. Richardson, D. E., H. R. Yao, K. M. Frank, and D. A. Bennett. 2000. Equilibria, kinetics, and mechanism in the bicarbonate activation of hydrogen peroxide: oxidation of sulfides by peroxymonocarbonate. J. Am. Chem. Soc. 122:1729-1739.[CrossRef]
28. Rokutan, K., J. A. Thomas, and H. Sies. 1989. Specific S-thiolation of a 30 KDa cytosolic protein from rat liver under oxidative stress. Eur. J. Biochem. 179:233-239.[Medline]
29. Sly, W. S., D. Hewett-Emmett, S. J. Dodgson, Y. S. Yu, and R. E. Tashian. 1983. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc. Natl. Acad. Sci. USA 80:2752-2756.
30. Sly, W. S., and P. Y. Hu. 1995. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem. 64:375-401.[CrossRef][Medline]
31. Spicer, S. S., Z. H. Ge, R. E. Tashian, D. J. Hazen-Martin, and B. Schulte. 1990. Comparative distribution of carbonic anhydrase isoenzymes III and II in rodent tissues. Am. J. Anat. 187:55-64.[CrossRef][Medline]
32. Stanton, L. W., P. A. Ponte, R. T. Coleman, and M. A. Snyder. 1991. Expression of CA III in rodent models of obesity. Mol. Endocrinol. 5:860-866.[Abstract]
33. Starke-Reed, P. E., and C. N. Oliver. 1989. Protein oxidation and proteolysis during aging and oxidative stress. Arch. Biochem. Biophys. 275:559-567.[CrossRef][Medline]
34. Tashian, R. E. 1989. The carbonic anhydrases: widening perspectives on their evolution, expression and function. Bioessays 10:186-192.[CrossRef][Medline]
35. Thomas, J. A., B. Poland, and R. Honzatko. 1995. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch. Biochem. Biophys. 319:1-9.[CrossRef][Medline]
36. Tybulewicz, V. L., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153-1163.[CrossRef][Medline]
37. Wetzel, P., T. Liebner, and G. Gros. 1990. Carbonic anhydrase inhibition and calcium transients in soleus fibers. FEBS Lett. 267:66-70.[CrossRef][Medline]
38. Wolfinger, R. D., G. Gibson, E. D. Wolfinger, L. Bennett, H. Hamadeh, P. Bushel, C. Afshari, and R. S. Paules. 2001. Assessing gene significance from cDNA microarray expression data via mixed models. J. Comput. Biol. 8:625-637.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|